Beyer-Westendorf J

No ORCID on file · 3 papers in corpus · active 2016-2021
2021
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin.
Research and practice in thrombosis and haemostasis ·doi:10.1002/rth2.12474

BackgroundRivaroxaban may induce heavy menstrual bleeding. It is unknown if this effect is dose related or if rivaroxaban is associated with more menstrual bleeding than aspirin.ObjectivesTo demonstrate and compare menstrual patterns and ac…

2021
Reproductive issues in women on direct oral anticoagulants.
Research and practice in thrombosis and haemostasis ·doi:10.1002/rth2.12512

Direct oral anticoagulants (DOACs) are replacing warfarin and other vitamin K antagonists for a wide range of indications. Advantages of DOAC therapy are fewer food and drug interactions and fixed dosing without routine laboratory monitorin…

2016
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.
Blood ·doi:10.1182/blood-2015-08-665927

Women receiving vitamin K antagonists (VKAs) require adequate contraception because of the potential for fetal complications. It is unknown whether the use of hormonal therapy, especially those containing estrogens, is associated with recur…